SV2006001970A - Hormonas de administracion transdermica que no necesitan potenciadores de penetracion ref. p-sv-77.461/cd - Google Patents
Hormonas de administracion transdermica que no necesitan potenciadores de penetracion ref. p-sv-77.461/cdInfo
- Publication number
- SV2006001970A SV2006001970A SV2004001970A SV2004001970A SV2006001970A SV 2006001970 A SV2006001970 A SV 2006001970A SV 2004001970 A SV2004001970 A SV 2004001970A SV 2004001970 A SV2004001970 A SV 2004001970A SV 2006001970 A SV2006001970 A SV 2006001970A
- Authority
- SV
- El Salvador
- Prior art keywords
- hormones
- penetration
- potentizers
- ref
- transdermal administration
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title abstract 3
- 239000005556 hormone Substances 0.000 title abstract 3
- 230000035515 penetration Effects 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 abstract 2
- 229960005352 gestodene Drugs 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
UN PARCHE QUE COMPRENDE UNA CAPA DE DROGA CON UN BAJO CONTENIDO DE HORMONAS, COMO POR EJEMPLO GESTODENO, Y OPCIONALMENTE UN ESTROGENO POR EJEMPLO ETINILESTRADIOL). AL APLICAR EL PARCHE A UNA MUJER, SE CONSIGUEN NIVELES EN PLASMA DE AL MENOS 1, ONG/ML DE GESTODENO EN CONDICIONES DE ESTADO ESTACIONARIO SIN NECESIDAD DE INCORPORAR POTENCIADORES DE PENETRACION NI MEJORADORES DE PERMEACION EN LA CAPA QUE CONTIENE DROGA, TAMBIEN SON SATISFACTORIOS LOS NIVELES EN PLASMA DE LAS HORMONAS QUE SE CONSIGUEN DURANTE TODO UN PERIODO DE AL MENOS 1 SEMANA, HACIENDO QUE EL PARCHE SE PUEDA APLICAR PARA UTILIZARLO EN ANTICONCEPCION FEMENINA CON EL CONCEPTO DE APLICAR PARA UTILIZAR EN ANTICONCEPCION FEMENIA CON EL CONCEPTO DE APLICAR EL PARCHE UNA VEZ A LA SEMANA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03078881 | 2003-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2006001970A true SV2006001970A (es) | 2006-02-16 |
Family
ID=34924031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2004001970A SV2006001970A (es) | 2003-12-12 | 2004-12-10 | Hormonas de administracion transdermica que no necesitan potenciadores de penetracion ref. p-sv-77.461/cd |
Country Status (23)
| Country | Link |
|---|---|
| EP (2) | EP2138169B1 (es) |
| CN (1) | CN101843603B (es) |
| AR (1) | AR046762A1 (es) |
| AT (1) | ATE457168T1 (es) |
| CR (1) | CR8465A (es) |
| CY (2) | CY1110637T1 (es) |
| DE (1) | DE602004025444D1 (es) |
| DK (2) | DK2138169T3 (es) |
| ES (2) | ES2340925T3 (es) |
| GT (1) | GT200400262A (es) |
| HN (1) | HN2004000526A (es) |
| HR (2) | HRP20100254T1 (es) |
| JO (1) | JO2606B1 (es) |
| ME (1) | ME01069B (es) |
| MY (2) | MY144053A (es) |
| PE (1) | PE20051035A1 (es) |
| PL (2) | PL2138169T3 (es) |
| PT (2) | PT2138169E (es) |
| RS (2) | RS51260B (es) |
| SI (2) | SI1541137T1 (es) |
| SV (1) | SV2006001970A (es) |
| TW (1) | TWI257299B (es) |
| UA (1) | UA89766C2 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1594483E (pt) | 2003-02-21 | 2006-12-29 | Schering Ag | Penso transdérmico estável aos uv |
| US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
| US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
| DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| WO2010042610A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc. | Transdermal delivery |
| CA2740002C (en) | 2008-10-08 | 2016-11-01 | Agile Therapeutics, Inc. | Transdermal delivery |
| CA2740005C (en) | 2008-10-08 | 2016-11-01 | Agile Therapeutics, Inc. | Transdermal delivery |
| EP2410859A4 (en) | 2009-03-27 | 2013-03-13 | Agile Therapeutics Inc | TRANSDERMAL ADMINISTRATION |
| DE102010040299A1 (de) * | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
| AU2015203180B2 (en) * | 2010-09-06 | 2016-06-30 | Bayer Intellectual Property Gmbh | Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner) |
| HRP20170292T1 (hr) | 2010-09-06 | 2017-04-21 | Bayer Intellectual Property Gmbh | Transdermalni flasteri niske doze s visokim otpuštanjem lijeka |
| HK1204287A1 (en) * | 2012-01-27 | 2015-11-13 | 敏捷治疗公司 | Transdermal hormone delivery |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4081537A (en) | 1975-10-10 | 1978-03-28 | Schering Aktiengesellschaft | Δ15 -Steroids and pharmaceutical compositions thereof |
| JP3238389B2 (ja) * | 1988-10-27 | 2001-12-10 | シエーリング アクチエンゲゼルシヤフト | ゲストデン含有の経皮適用のための薬剤 |
| PT99338A (pt) | 1990-10-29 | 1992-10-30 | Alza Corp | Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica |
| US5512292A (en) | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
| DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
| DE4329242A1 (de) * | 1993-08-26 | 1995-03-02 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Gestodenester |
| DE4405898A1 (de) | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
| DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
| EP1242012B1 (en) | 1999-11-24 | 2009-12-30 | Agile Therapeutics, Inc. | Improved transdermal contraceptive delivery system and process |
| DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
| TWI287455B (en) | 2000-12-05 | 2007-10-01 | Noven Pharma | Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
-
2004
- 2004-10-12 UA UAA200607580A patent/UA89766C2/ru unknown
- 2004-11-18 JO JO2004159A patent/JO2606B1/en active
- 2004-12-10 SV SV2004001970A patent/SV2006001970A/es not_active Application Discontinuation
- 2004-12-10 PL PL09173898T patent/PL2138169T3/pl unknown
- 2004-12-10 SI SI200431404T patent/SI1541137T1/sl unknown
- 2004-12-10 ES ES04078365T patent/ES2340925T3/es not_active Expired - Lifetime
- 2004-12-10 AT AT04078365T patent/ATE457168T1/de active
- 2004-12-10 AR ARP040104605A patent/AR046762A1/es not_active Application Discontinuation
- 2004-12-10 DK DK09173898.9T patent/DK2138169T3/da active
- 2004-12-10 EP EP09173898.9A patent/EP2138169B1/en not_active Expired - Lifetime
- 2004-12-10 RS RSP-2010/0202A patent/RS51260B/sr unknown
- 2004-12-10 MY MYPI20045107A patent/MY144053A/en unknown
- 2004-12-10 PT PT91738989T patent/PT2138169E/pt unknown
- 2004-12-10 TW TW093138443A patent/TWI257299B/zh not_active IP Right Cessation
- 2004-12-10 DE DE602004025444T patent/DE602004025444D1/de not_active Expired - Lifetime
- 2004-12-10 PT PT04078365T patent/PT1541137E/pt unknown
- 2004-12-10 GT GT200400262A patent/GT200400262A/es unknown
- 2004-12-10 PE PE2004001230A patent/PE20051035A1/es active IP Right Grant
- 2004-12-10 ES ES09173898.9T patent/ES2445690T3/es not_active Expired - Lifetime
- 2004-12-10 SI SI200432127T patent/SI2138169T1/sl unknown
- 2004-12-10 PL PL04078365T patent/PL1541137T3/pl unknown
- 2004-12-10 ME MEP-2010-79A patent/ME01069B/me unknown
- 2004-12-10 CN CN2010101564978A patent/CN101843603B/zh not_active Expired - Lifetime
- 2004-12-10 DK DK04078365.6T patent/DK1541137T3/da active
- 2004-12-10 HN HN2004000526A patent/HN2004000526A/es unknown
- 2004-12-10 EP EP04078365A patent/EP1541137B1/en not_active Expired - Lifetime
- 2004-12-10 RS YU20140050A patent/RS53182B/sr unknown
-
2006
- 2006-06-20 CR CR8465A patent/CR8465A/es unknown
-
2010
- 2010-03-31 MY MYPI2010001448 patent/MY152750A/en unknown
- 2010-05-04 HR HR20100254T patent/HRP20100254T1/hr unknown
- 2010-05-07 CY CY20101100401T patent/CY1110637T1/el unknown
-
2014
- 2014-01-24 HR HRP20140077TT patent/HRP20140077T1/hr unknown
- 2014-02-06 CY CY20141100099T patent/CY1115064T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20100143A7 (es) | Hormonas de administración transdérmica que no necesitan potenciadores de penetración | |
| SV2006001970A (es) | Hormonas de administracion transdermica que no necesitan potenciadores de penetracion ref. p-sv-77.461/cd | |
| CY1125035T1 (el) | Ουσια-φορεας φαρμακων και κιτ ουσιας-φορεα φαρμακων για αναστολη ινωσης | |
| ATE329586T1 (de) | Zusammensetzungen enthaltend carotenoide und deren verwendung zur verhinderung hormon- induzierter nebenwirkungen | |
| MX2022008277A (es) | Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas. | |
| ES2190472T3 (es) | Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno. | |
| ES2167061T3 (es) | Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino. | |
| AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
| ECSP003847A (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco | |
| AR033808A1 (es) | Una composicion topica de anestesia local y los parches y los envases que la contienen | |
| SV2006002165A (es) | Regimenes y kits de progestina ciclica ref. am101677 | |
| AR021459A1 (es) | PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS. | |
| EA201590907A1 (ru) | Усиленные полиамином составы для ионтофореза соединения триптана | |
| AR044350A1 (es) | Manguito y parche analgesico microencapsulado de uso topico para el tratamiento del dolor | |
| EA200702102A1 (ru) | Пластинки, содержащие стероидные гормоны | |
| CR8059A (es) | Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activas | |
| HN2001000038A (es) | Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina | |
| UY28668A1 (es) | Hormonas de administración transdérmica que no necesitan potenciadores de penetración | |
| CU23649B7 (es) | Hormonas de administración transdérmica que no necesitan potenciadores de penetración | |
| WO2006091719A3 (en) | Compositions and methods enhancing transdermal delivery of drugs and biologics | |
| AR044939A1 (es) | Sistema de administracion para medicaciones topicas | |
| AR029096A1 (es) | Combinacion de sustancias activas que contiene montirelina y un compuesto de efecto opioide, medicamentos y formulaciones medicamentosas que contienen dicha combinacion y su uso para la preparacion de medicamentos para tratamiento del dolor | |
| ATE269063T1 (de) | Formulierungen zur transdermalen verabreichung von fenoldopam | |
| WO2007016146A3 (en) | Method for retarding systemic delivery rate for easily absorbable active agents | |
| UY28579A1 (es) | Formulaciones farmacéuticas transdermicas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |